RepliCel Life Sciences Inc (REPCF)
0.0428
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
RepliCel Life Sciences 1 Year Total Returns (Daily): -56.33% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -56.33% |
May 16, 2024 | -61.58% |
May 15, 2024 | -61.58% |
May 14, 2024 | -64.65% |
May 13, 2024 | -64.65% |
May 10, 2024 | -44.36% |
May 09, 2024 | -44.36% |
May 08, 2024 | -43.63% |
May 07, 2024 | -43.63% |
May 06, 2024 | -43.63% |
May 03, 2024 | -43.63% |
May 02, 2024 | -43.63% |
May 01, 2024 | -43.63% |
April 30, 2024 | -54.13% |
April 29, 2024 | -54.13% |
April 26, 2024 | -54.13% |
April 25, 2024 | -54.13% |
April 24, 2024 | -54.13% |
April 23, 2024 | -58.00% |
April 22, 2024 | -58.00% |
April 19, 2024 | -43.63% |
April 18, 2024 | -61.05% |
April 17, 2024 | -61.05% |
April 16, 2024 | -54.43% |
April 15, 2024 | -54.43% |
Date | Value |
---|---|
April 12, 2024 | -58.61% |
April 11, 2024 | -58.61% |
April 10, 2024 | -66.74% |
April 09, 2024 | -66.74% |
April 08, 2024 | -66.74% |
April 05, 2024 | -64.42% |
April 04, 2024 | -61.05% |
April 03, 2024 | -61.05% |
April 02, 2024 | -61.05% |
April 01, 2024 | -61.05% |
March 28, 2024 | -62.75% |
March 27, 2024 | -62.75% |
March 26, 2024 | -62.75% |
March 25, 2024 | -62.75% |
March 22, 2024 | -58.89% |
March 21, 2024 | -58.69% |
March 20, 2024 | -58.69% |
March 19, 2024 | -58.69% |
March 18, 2024 | -58.69% |
March 15, 2024 | -58.69% |
March 14, 2024 | -61.40% |
March 13, 2024 | -67.87% |
March 12, 2024 | -64.47% |
March 11, 2024 | -64.47% |
March 08, 2024 | -69.93% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.32%
Minimum
Jul 11 2022
251.6%
Maximum
Oct 04 2021
-9.57%
Average
-27.12%
Median
May 09 2023
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | -10.35% |
Aurinia Pharmaceuticals Inc | -46.22% |
Edesa Biotech Inc | -30.85% |
Lexaria Bioscience Corp | 326.5% |
InMed Pharmaceuticals Inc | -74.36% |